REVELIO Planned Participant-Level Validation to Separate New Drivers From Repeated Sensor Windows

The REVELIO protocol plans to keep each participant’s data entirely within either training or testing during model validation. This addresses a specific risk: repeated sensor windows from one driver can make an apparent test less independent than it looks.

Many windows do not create many drivers

The planned high-frequency data will be divided into sessions, scenarios and time windows. Windows from the same person can share driving habits and physiological characteristics. If they appeared on both sides of a model evaluation, performance could partly reflect recognition of that person rather than generalization to an unseen driver.

The protocol specifies grouped evaluation

The authors propose leave-one-subject-out or equivalent grouped cross-validation. Preprocessing and feature selection are to be learned within training data and applied unchanged to held-out data. Nested procedures are planned where feasible. These are methodological commitments in a protocol, not evidence that a completed model achieved a particular accuracy.

Internal separation does not complete external validation

Holding out participants helps assess performance within the recruited sample. It does not establish transportability to new roads, devices, populations or competing causes of poor driving. The publication supplies a reviewable strategy for limiting information leakage. A future result should be assessed against what was actually implemented, while retaining the distinction between participant-level internal validation and independent external testing.

Related analysis: the source’s broader findings and limitations.

Research cited

Deuber and colleagues (2026). Protocol for the REVELIO test-track pilot study: A randomised, controlled, single-centre trial in healthy recreational cannabis users investigating real-time in-vehicle detection of cannabis-impaired driving.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Carryover Testing Challenged the Analytical Sequence, Not the Newborn’s Exposure History

The neonatal assay’s carryover assessment examined whether a preceding high-concentration sample could affect a later measurement. It addressed an instrument-process question, not a biological exposure pathway. The protocol deliberately stressed the sequence The investigators used samples at twice the upper quantification limit followed by low-range samples. They considered contamination associated…

Spread the love

Read Article: Carryover Testing Challenged the Analytical Sequence, Not the Newborn’s Exposure History

The Paired Cord-and-Meconium Study Was Not a Survey of All Births

The forty-six specimen pairs came from archived cases in which both tests had been clinically ordered. Their cannabinoid-positive proportions were not population prevalence estimates. Selection followed the availability of paired orders Investigators sought residual meconium and cord tissue from the same newborn where testing for both matrices had been requested….

Spread the love

Read Article: The Paired Cord-and-Meconium Study Was Not a Survey of All Births

A Half-LLOQ Check Was Not the Same as Independently Determining Every Detection Limit

The neonatal cannabinoid study explicitly stated that each analyte’s detection limit was not specifically determined. It checked performance at half the lower quantification limit instead. The validation described what was actually tested The researchers verified relevant acceptance criteria and a signal-to-noise ratio of at least three at concentrations equivalent to…

Spread the love

Read Article: A Half-LLOQ Check Was Not the Same as Independently Determining Every Detection Limit

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us